Status:
COMPLETED
Toradol v. Celecoxib for Postoperative Pain
Lead Sponsor:
Michael Ulm, MD
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Randomized control trial between ketorolac versus celecoxib for postoperative pain following hysterectomy.
Detailed Description
Purpose: To determine if Celebrex (Celecoxib) is as effective as Toradol (Ketorolac) at controlling postoperative pain when given in addition to standard postoperative pain control regimens. Rationa...
Eligibility Criteria
Inclusion
- Patients undergoing hysterectomy
Exclusion
- Coronary Artery Disease
- Peptic Ulcer Disease
- Chronic Renal Disease
- Liver disease
- Alcohol Abuse
- Daily narcotic usage
- Narcotic use 24 hours prior to surgery
- Crohn's Disease
- History of myocardial infarction
- History of stroke
- Preoperative hematocrit less than 24
- Asthma
- Ulcerative Colitis
- Diverticulitis
- Aspirin Allergy
- Sulfonamide Allergy
- Pre-operative pain score of greater than 3
- Patients undergoing procedures that may involve bowel resection or bowel reanastomosis.
- Allergy to any non-steroidal anti-inflammatory drug
- Cardiac anomaly or disease
- Congestive Heart Failure
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2017
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT03331315
Start Date
September 1 2013
End Date
January 1 2017
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Hospital System
Memphis, Tennessee, United States, 38104